Podcasts about otsuka

In this CME podcast, Dr. Andrew Cutler and Dr. Roger McIntyre discuss the use of potentially unsafe drug combinations in patients with treatment-resistant psychiatric conditions. They review situations where complex medication regimens may be necessary and how clinicians may proceed in these instances. By addressing these topics, the podcast offers guidance on balancing the potential benefits of combination therapies with the risks associated with polypharmacy in psychiatric care.  Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objectives: After completing this educational activity, you should be better able to: Identify common potentially unsafe drug combinations that may be considered in treatment-resistant cases Evaluate the risks and benefits of prescribing potentially unsafe drug combinations for treatment-resistant patients, considering factors such as efficacy, adverse effects, and patient-specific characteristics Develop strategies to monitor and manage patients prescribed potentially unsafe drug combinations Accreditation: In support of improving patient care, this activity has been planned and implemented by HMP Education and Neuroscience Education Institute (NEI). HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Activity Overview: This activity is available with synchronized audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit.   Estimated Time to Complete: 1 hour. Released: March 26, 2025*   Expiration: March 25, 2028 *NEI maintains a record of participation for six (6) years. CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD25-01 Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ HMP Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse: ANCC contact hours This continuing nursing education activity awards 1.00 contact hour. Provider approved by the California Board of Registered Nursing, Provider #18006 for 1.00 contact hour. Nurse Practitioner: ACCME AMA PRA Category 1 Credit™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 1.00 continuing education hour of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 1.00 contact hour (.10 CEU). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI and HMP Education must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and are unable to report your claimed credit after this 60-day period. Ensure your profile includes your DOB and NABP ID. Physician Associate/Assistant: AAPA Category 1 CME credits HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.00 AAPA Category 1 credit. Approval is valid until March 25, 2028. PAs should only claim credit commensurate with the extent of their participation. Psychology: APA CE credits Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. This activity awards 1.00 CE Credit. Social Work: ASWB-ACE CE credits As a Jointly Accredited Organization, HMP Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this internet enduring course receive 1.00 general continuing education credit. Non-Physician Member of the Healthcare Team: Certificate of Participation HMP Education awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit™) to a participant who successfully completes this educational activity. Interprofessional Continuing Education: IPCE credit for learning and change This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change. Peer Review: The content was peer-reviewed by an MD, MPH specializing in forensics, psychosis, schizophrenia, mood disorders, anxiety, and cognitive disorders — to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI and HMP Education take responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Any relevant financial relationships were mitigated prior to the activity being planned, developed, or presented. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, New York Chief Medical Officer, Neuroscience Education Institute, Malvern, Pennsylvania Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Roger S. McIntyre, MD, FRCPC Professor, Departments of Psychiatry and of Pharmacology, University of Toronto, Toronto, Ontario, Canada CEO, Braxia Scientific Corp, Toronto, ON, Canada Grant/Research: Canadian Institutes of Health Research, China National Natural Research Foundation, Global Alliance for Chronic Diseases, Milken Institute Consultant/Advisor: Alkermes, Atai Life Sciences, Axsome, Bausch Health, Biogen, Eisai, Intra-Cellular, Janssen, Kris, Lundbeck, Mitsubishi Tanabe, Neumora Therapeutics, Neurocrine, NewBridge Pharmaceuticals, Novo Nordisk, Otsuka, Pfizer, Purdue, Sage, Sanofi, Sunovion, Takeda, Viatris The remaining Planning Committee members, Content Editors, Peer Reviewer, NEI and HMP planners/staff have no financial relationships to disclose. NEI and HMP Education planners and staff include Gabriela Alarcón, PhD, Ali Holladay, Andrea Zimmerman, EdD, CHCP, Brielle Calleo, and Steven S. Simring, MD, MPH. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported solely by the provider, NEI.

www.marktreichel.comhttps://www.linkedin.com/in/mark-treichel/NCUA Predictions: What Will the Do in 2025?Treichel: [00:00:00] Hey everyone, this is Mark Treichel with another episode of With Flying Colors. Today I am flying solo and I am calling this podcast something like what I expect from NCUA in 2025. In preparing for today's show, I took some notes going back and looking at NCUA's Agenda from their board action taken in 2025 and am gleaning based on the Trump administration and the Helpman leadership.What may or what may not happen in 2025 compared to 2024. When you go back and look at 2025. They had canceled two board meetings. So that was one takeaway. They canceled the March, 2024 board meeting, which was the first time in a long time that that had happened. And they canceled the June, 2024 meeting.So this was under then [00:01:00] chairman Todd Harper, who is now a board member at large, although he came close to being named vice chair, and you can check out some of my past podcasts for discussions on why that may have blown up anyway. It things continue to blow up at the board level, but I'll get to that here shortly.All right. They canceled 2 board meetings and they held for N. C. U. S. I. F. share insurance fund briefings. I report on those quite a bit here and on linked in because that's 1 of the few windows to generic camel code ratings. You can see when camel code ratings go up and they did 4 of those. in 2024.I'm expecting they'll do four of those in 2025. They did one cyber security update briefing and they did a new charter update and briefing and tip to what I might say in the future. I think there will be more briefings because I don't think the board will be acting on much because I don't think the board [00:02:00] is currently getting along because of the kerfuffle on NSF and overdraft fees.All right. So other things they did they did a proposed succession planning rule and a final succession planning rule. They did an incentive based compensation proposal, which I think will go nowhere in 2025. That was put out there because Biden's administration required it from all. Banking agencies and under the Trump administration there will be less or zero regulation.And I don't see them wanting to put proposals in on incentives. If you'd know what I mean. In July, there was a loan rate ceiling approval to. re approve utilization of the 18 percent rate. That's what they do every time. The trade associations come out saying you should allow that to go up or you should make it based on variability.If NCOA was ever going to raise it, it would have been last year and or the year before. They [00:03:00] didn't seize that opportunity because they thought it would have been egregiously harmful to credit unions and credit union members. I disagree with that, but they will vote on that again because they have to vote on it and they will likely just do what they've done umpteen years in a row, which is reaffirmed the 18%.I expect that to happen in July again. All right. What else is going to be happening? Potentially, they did have a board appeal in August. By the way, they typically don't have open board meetings in August. That was a closed a closed item where a credit union appealed something without revealing what I know relative to that.That was a field of membership appeal. There was a fair hiring and banking proposal, which doesn't need to repeat in 2025. They simplified the insurance rules. And then when you get close to the end of the year, what happens at the end of the year and CUA approves their budget. But before they approve their budget, they do a budget briefing.A little [00:04:00] bit of history on the budget briefings. The budget briefing started when I was the deputy executive director and they were started by Dennis Dollar. And I remember saying to that executive director, Len Skiles, if you do this, Make sure you want to do it and it was for transparency. But once you start something, it's very difficult to stop it.And I'll get to that and why I'm making that point. I'll get to it now, but I'll refer to it again. So NCOA did stop it. I believe it was under the Matt's administration and the trade associations got upset because that was their opportunity. One of their opportunities to show value saying your budget's too high.Here's why we think it's too high. And through assistance from Senator Mark Warner in Virginia, they were able to get the Federal Credit Union Act proposed, requiring NCUA to do a budget briefing. They are required to do a budget briefing. I believe they will do a budget briefing. I'm not so sure they will do a budget.They're not [00:05:00] required to do a budget, and they are required to do a budget briefing. They're not required to do a budget, and that's because there is a two year budget. So I'll get to that and why I think that they may not do a budget when we walk through what I think will happen in totality in 2025. The NCOA approved their annual performance plan, which is linked to their strategic plan, already in January.That was one of the last things they did prior to Hauptmann taking over. So they don't need to do that annual plan, but they do need to do another strategic plan, and that would be due by the end of 2025 for the years 2026 through 2030. Will they do that? We will see. All right. So when you look at what is going to happen and what I predict will happen in 2024, that's a little bit about what happened.What I'm predicting in 2024 is that the theme of canceling board meetings will continue. They, as I mentioned, they canceled March and June. I'm [00:06:00] expecting that they may cancel April or May. Or June or July, I don't believe they're going to have enough briefings to keep an agenda full. I don't believe they're going to agree on enough things because of the arguments they're having about about NSF fees and overdraft fees being reported by over a billion dollar credit unions.There's two approaches here. Kyle Hauptman canceled and changed the. Way that billion dollar plus credit unions were going were reporting for three quarters on NSFs and overdrafts saying that it's overkill and it's onerous on the credit unions, et cetera, et cetera, and that they would be looking at that during part of the examinations and then after he announced that at GAC and then.Board member Harper and board member Otsuka came out with their own press releases, and I understand they did a full court press on [00:07:00] Capitol Hill on the topic and came out saying that what's wrong with transparency? There should be transparency here. Why are you stopping something that was started and that credit unions had been providing and that's bad for members?So that's the nexus I wanted to say where I mentioned with Dennis Dollar that when he started the budget briefings, I thought they would never be stopped. And it's hard to stop something when you do. What happened? Debbie Matt stopped the budget briefings, and then lo and behold, the Federal Credit Union Act was changed and INSU 8 was required.to do that. So at some point, whether it's when the next time there's a D in the White House or there's a D in running the Dems have control of Congress. And the White House, you're going to see more on the fee situation. You're going to see NCOA go back to collecting this data. Will it be in 4 years?Will it be in 8 years? Will it be sometime sooner than that? [00:08:00] My guess is not before the four year period. I can't see how it went flip floppi...

Prince Hisahito, the son and third child of Japan's Crown Prince Akishino and Crown Princess Kiko, attended the graduation ceremony of the University of Tsukuba's Senior High School at Otsuka in Tokyo on Tuesday morning.

Rabbi Richard Louis Price, M.D. is a Yale & Columbia University-trained psychiatry professor at Weill Cornell Medical College/New York-Presbyterian Hospital. Over the past two decades, he has evaluated over 20,000 patients serving as a medical director at Achieve Behavioral Health in Monsey; Rockland TMS & Wellness Center; Hamaspik of Orange and Rockland Counties; Volunteer Counseling Services in New City; ParCare in Brooklyn, Chai Urgent Care Centers of New York, Pennsylvania, and Florida,, and has a private pediatric and adult psychotherapy and psychopharmacology practice in Monsey, New York. Dr. Price is triple board certified in Psychiatry, Consultation-Liaison/Mind-Body Medicine, and Addiction Medicine and has been awarded numerous patents in the United States, Canada, Europe, and Israel for a novel pharmacotherapy for the treatment of both core and associated symptoms of Autism Spectrum Disorder. Dr. Price has served on the advisory boards and as a national speaker for several pharmaceutical companies, such as Abbvie, Alkermes, Allergan, Almatica, Axsome, Idorsia, Intracellular, Janssen, Jazz, Lumbeck, Neuronetics, Otsuka, Supernus, and Vanda and has been recognized as a top Medical Educator by the American Psychiatric Association. He is also a professional singer and taekwondo black belt.     ADHD ARTICLE PUBLISHED: https://pmc.ncbi.nlm.nih.gov/articles/PMC10374479/ HISTORICAL OVERVIEW OF VILOXAZINE: https://pmc.ncbi.nlm.nih.gov/articles/PMC8219567/  

Quels sont les développements les plus marquants dans la compréhension des mécanismes biologiques des maladies auto-immunes systémiques ? En quoi les thérapies innovantes telles que les CAR T-cells et les anticorps bi-spécifiques pourraient transformer la prise en charge de ces maladies ? Quels sont les principaux défis des prochaines années dans le champ des maladies auto-immunes systémiques ? Le Pr Xavier Mariette, chef du service d'immuno-rhumatologie à l'hôpital Bicêtre, nous éclaire à ce sujet. Notre invité déclare des liens d'intérêt avec BMS, GSK, Novartis, Otsuka, et Pfizer. L'équipe : Comité scientifique : Pr Jérémie Sellam, Pr Thao Pham, Dr Catherine Beauvais, Dr Véronique Gaud-Listrat, Dr Céline Vidal, Dr Sophie Hecquet Animation : Marguerite de Rodellec Production : MedShake Studio Soutien institutionnel : Pfizer

In today's episode we discuss Vu's newest watch, the Otsuka Lotec No. 7.5. Coming right off the amazing success of the No. 6 winning the GPHG Challenge Prize, the arrival of the No. 7.5 couldn't have been better timed. Although they share a design language, the No. 6 and No. 7.5 are very different watches. Vu explains what he loves about the design of the 7.5 which takes some inspiration from vintage cameras. Otsuka Lotec No. 7.5 page

Are you underestimating the power of ADHD in achieving extraordinary success? Join us as Tracy Otsuka, author of "ADHD for Smartass Women," delves into her personal and her son's enlightening journey with ADHD. In this episode, Tracy unravels the unique manifestations of ADHD in women and the transformative power of embracing neurodivergence. Explore the misunderstood dimensions of ADHD, from hyperactivity to inattentiveness, and discover how shifting perspectives can unlock remarkable potential and creativity. To check out Tracy's book, "ADHD for Smart Ass Women: How to Fall in Love with Your Neurodivergent Brain", head on over to Amazon (affiliate): https://amzn.to/4gmyM1h To check out the YouTube (video podcast), visit: https://youtu.be/F8Zog7zI_rc Disclaimer: Not advice. Educational purposes only. Not an endorsement for or against. Results not vetted. Views of the guests do not represent those of the host or show. Click here to join PodMatch (the "AirBNB" of Podcasting): https://www.joinpodmatch.com/drchrisloomdphd Enhance your productions through Descript (affiliate): https://get.descript.com/gaei637mutik Check out TubeBuddy, the all-in-one platform that helps you grow and scale your YouTube channel (affiliate): https://www.tubebuddy.com/pricing?a=FinancialFreedomPodcast Click here to check out our Amazon product of the day (affiliate): https://amzn.to/4gkgVIk We couldn't do it without the support of our listeners. To help support the show: CashApp- https://cash.app/$drchrisloomdphd Venmo- https://account.venmo.com/u/Chris-Loo-4 Spotify- https://podcasters.spotify.com/pod/show/christopher-loo/support Buy Me a Coffee- https://www.buymeacoffee.com/chrisJx Click here to schedule a 1-on-1 private coaching call: https://www.drchrisloomdphd.com/book-online Click here to check out our bookstore, e-courses, and workshops: https://www.drchrisloomdphd.com/shop Click here to purchase my books on Amazon: https://amzn.to/2PaQn4p For audiobooks, visit: https://www.audible.com/author/Christopher-H-Loo-MD-PhD/B07WFKBG1F Follow our YouTube channel: https://www.youtube.com/chL1357 Follow us on Twitter: https://www.twitter.com/drchrisloomdphd Follow us on Instagram: https://www.instagram.com/thereal_drchrisloo Follow us on Threads: https://www.threads.net/@thereal_drchrisloo Follow us on TikTok: https://www.tiktok.com/@drchrisloomddphd Follow our Blog: https://www.drchrisloomdphd.com/blog Follow the podcast on Spotify: https://open.spotify.com/show/3NkM6US7cjsiAYTBjWGdx6?si=1da9d0a17be14d18 Subscribe to our Substack newsletter: https://substack.com/@drchrisloomdphd1 Subscribe to our Medium newsletter: https://medium.com/@drchrisloomdphd Subscribe to our LinkedIn newsletter: https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=6992935013231071233 Subscribe to our email list: https://financial-freedom-podcast-with-dr-loo.kit.com/ Thank you to all of our sponsors and advertisers that help support the show! Financial Freedom for Physicians, Copyright 2024 --- Support this podcast: https://podcasters.spotify.com/pod/show/christopher-loo/support

In this CME podcast, Dr. Andrew Cutler interviews Dr. Jonathan Meyer about the history of muscarinic receptor science in schizophrenia and how that informs the mechanisms of action of novel muscarinic-targeting drugs for this disorder. They also discuss the efficacy and safety of these drugs and provide practical strategies for prescribing xanomeline-trospium.  Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objectives: After completing this educational activity, you should be better able to: Discuss the history of muscarinic receptor science and the role of muscarinic receptors in schizophrenia treatment Differentiate novel and in-development muscarinic-targeting treatments for schizophrenia based on their unique mechanisms of action, efficacy, and tolerability data   Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Activity Overview: This activity is available with audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit.   Estimated Time to Complete: 1 hour Released: November 27, 2024*   Expiration: November 26, 2027 *NEI maintains a record of participation for six (6) years. CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD24-SCHIZ01  Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ NEI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity Nurse: ANCC contact hours NEI designates this Enduring Material for a maximum of 1.0 ANCC contact hour Nurse Practitioner: ACCME AMA PRA Category 1 Credit™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 1.0 continuing education hour of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 1.0 contact hour (.10 CEU). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and is unable to report your claimed credit after this 60-day period. Physician Associate/Assistant: AAPA Category 1 CME credits NEI has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.0 AAPA Category 1 credit. Approval is valid until November 26, 2027. PAs should only claim credit commensurate with the extent of their participation. Psychology: APA CE credits Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. Social Work: ASWB-ACE CE credits As a Jointly Accredited Organization, NEI is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this internet enduring course receive 1 general continuing education credits. Non-Physician Member of the Healthcare Team: Certificate of Participation NEI awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)™) to a participant who successfully completes this educational activity. Interprofessional Continuing Education: IPCE credit for learning and change This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change. Peer Review: The content was peer-reviewed by an MD specializing in psychiatry and psychopharmacology — to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, NY Chief Medical Officer, Neuroscience Education Institute, Malvern, PA Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Jonathan M. Meyer, MD Voluntary Clinical Professor, Department of Psychiatry, University of California, San Diego School of Medicine, La Jolla, CA Consultant/Advisor: AbbVie, Alkermes, Bristol Myers Squibb, Intra-Cellular, Neurocrine, Sumitomo, Teva Speakers Bureau: AbbVie, Alkermes, Axsome, Bristol Myers Squibb, Intra-Cellular, Neurocrine, Teva The remaining Planning Committee members, Content Editors, Peer Reviewer, and NEI planners/staff have no financial relationships to disclose. NEI planners and staff include Caroline O'Brien, Gabriela Alarcón, PhD, Meghan M. Grady, BA, Andrea Zimmerman, EdD, CHCP, and Brielle Calleo. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement Contact Us: For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported by an educational grant from Bristol Myers Squibb.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sarah Shizuko Morimoto, PsyD Digital therapeutics are a rapidly developing type of treatment option across several therapeutic areas, including mental health. And while the technology is advancing rapidly, the science behind it needs time to catch up, so it's important to evaluate the supporting evidence when considering digital therapeutics for mental health.1 Joining Dr. Charles Turck to share her insights on how we can assess digital therapeutics is Dr. Sarah Shizuko Morimoto, Associate Professor of Population Health Sciences at the University of Utah in Salt Lake City. Reference: American Psychiatric Association. Accessed July 3, 2024. https://www.psychiatry.org/psychiatrists/practice/mental-health-apps/the-app-evaluation-model Dr. Morimoto is a paid consultant of Otsuka. November 2024 US.UNB.X.24.00100

In a recent episode of 'ADHD for Smart Ass Women,' I had the incredible opportunity to chat with host Tracy Otsuka about my journey of growing up with diagnosed ADHD and how that has shaped my life and my business. We dove into how my diagnosis at a younger age helped me understand myself better, how keeping a persistent mindset has helped me overcome many new challenges in my life, and how these obstacles have turned into stepping stones throughout my business and other areas of my life. Please don't let your current obstacles hold you back; you have a unique set of gifts to share. Tracy OtsukaHi, I'm Tracy. I'm a mother, author, podcaster, certified ADHD coach, and lawyer committed to changing the conversation around ADHD.Tracy's WebsiteListen to the Original Episode HereConnect with Molly ClaireMolly's Website: MollyClaire.ComMaster Coach Training 2025 Application Open Have a question or thoughts about the podcast? Don't hesitate to contact Molly at:Instagram | Molly Claire Coaching IGmolly@mollyclaire.comFacebookMolly's book: The Happy Mom Mindset: mollyclaire.com/bookPlease help Molly reach even more like-minded individuals! Simply post a review of the podcast on your favorite platform (or two). It is so appreciated.Access the full show notes and all links

In this episode we talk about Lydia's trip to Geneva for the GPHG Awards show and gala. Also Vu finally let her borrow a watch, and it's his current favorite one!

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Robert McCarron, MD Guest: Arwen Podesta, MD Digital therapeutics are a relatively new and intriguing treatment option in mental health care but translating them from a clinical trial to clinical practice can be challenging. That's why Drs. Robert McCarron and Arwen Podesta join Dr. Charles Turck to share strategies for incorporating digital therapeutics into clinical practice. Dr. McCarron is a Professor in the Department of Psychiatry and Human Behavior at the University of California, Irvine School of Medicine, and Dr. Podesta is the President of the Louisiana Psychiatric Medical Association. Drs. McCarron and Podesta are consultants for Otsuka. September 2024 US.UNB.X.24.00073

In this CME episode, Drs. Andrew Cutler and Roger McIntyre discuss the challenges and importance of diagnosing bipolar disorder as early as possible in the course of the illness. They also review strategies to achieve a correct diagnosis to provide the most efficacious and tolerable treatments available for bipolar disorder. Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objectives: After completing this educational activity, you should be better able to: Employ effective screening tools and assessment strategies to enhance diagnostic accuracy and achieve early diagnosis of bipolar disorder Develop patient-centered treatment plans that incorporate current evidence and individual patient factors Utilize shared decision-making approaches to optimize treatment outcomes for patients with bipolar disorder Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Activity Overview: This activity is available with audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit.   Estimated Time to Complete: 1 hour Released: November 01, 2024*   Expiration: October 31, 2027 *NEI maintains a record of participation for six (6) years. CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD24-BD Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ NEI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity Nurse: ANCC contact hours NEI designates this Enduring Material for a maximum of 1.0 ANCC contact hour Nurse Practitioner: ACCME AMA PRA Category 1 Credit™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 1.0 continuing education hour of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 1.0 contact hour (.10 CEU). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and is unable to report your claimed credit after this 60-day period. Physician Associate/Assistant: AAPA Category 1 CME credits NEI has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.0 AAPA Category 1 credit. Approval is valid until OCtober 31, 2027. PAs should only claim credit commensurate with the extent of their participation. Psychology: APA CE credits Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. Social Work: ASWB-ACE CE credits As a Jointly Accredited Organization, NEI is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this internet enduring course receive 1 general continuing education credits. Non-Physician Member of the Healthcare Team: Certificate of Participation NEI awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)™) to a participant who successfully completes this educational activity. Interprofessional Continuing Education: IPCE credit for learning and change This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change. Peer Review: The content was peer-reviewed by an MD, MPH specializing in forensics, psychosis, schizophrenia, mood disorders, anxiety, cognitive disorders — to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, New York Chief Medical Officer, Neuroscience Education Institute, Malvern, Pennsylvania Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Roger S. McIntyre, MD, FRCPC Professor, Departments of Psychiatry and of Pharmacology, University of Toronto, Toronto, Ontario, Canada CEO, Braxia Scientific Corp, Toronto, Ontario, Canada Grant/Research: Canadian Institutes of Health Research, China National Natural Research Foundation, Global Alliance for Chronic Diseases, Milken Institute Consultant/Advisor: Alkermes, Atai Life Sciences, Axsome, Bausch Health, Biogen, Eisai, Intra-Cellular, Janssen, Kris, Lundbeck, Mitsubishi Tanabe, Neumora Therapeutics, Neurocrine, NewBridge Pharmaceuticals, Novo Nordisk, Otsuka, Pfizer, Purdue, Sage, Sanofi, Sunovion, Takeda, Viatris The remaining Planning Committee members, Content Editors, Peer Reviewer, and NEI planners/staff have no financial relationships to disclose. NEI planners and staff include Caroline O'Brien, Gabriela Alarcón, PhD, Andrea Zimmerman, EdD, CHCP, and Brielle Calleo. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement Contact Us: For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported by an unrestricted educational grant from Alkermes, Inc.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Maggie Emerson, DNP, APRN, PMHNP-BC Guiding patients and caregivers through the fast-moving landscape of digital therapeutics can be a challenging but worthwhile part of providing effective and accessible care. That's why Dr. Charles Turck speaks with Dr. Maggie Emerson about partnering with patients and caregivers around this relatively new treatment in mental health care. Dr. Emerson is a Clinical Associate Professor at the University of Nebraska Medical Center College of Nursing in Omaha. Dr. Emerson is a paid consultant of Otsuka. September 2024 US.UNB.X.24.00082

In this episode, we take a deep dive into the often-mystifying Japanese business practices that foreigners in Japan struggle to navigate. Intercultural facilitator Masafumi Otsuka sheds light on puzzling practices like "Why Japanese managers change jobs every three years" and "Why they always see the glass as half empty." Masa offers a logical breakdown of the periodic job rotation system and Japan's risk-averse decision-making process.We also explore key cultural concepts that are often misunderstood by Westerners—such as Nemawashi, Genten Shugi, and Kyochosei—all explained by Masa in a fun and enlightening way.Masa shares personal stories about his own struggles, including returning to Japan as a student, the politics behind leaving a high-profile job, and what it's like to feel "1/3 Japanese, 1/3 American, and 1/3 confused." This episode is packed with insights and humor, offering a unique perspective on the complexities of Japanese business culture. Other highlights from our conversation:Why there is no Japanese word for "procrastinate"The unspoken rule for Japanese overseas returnee studentsThe priority in Japan is harmonizeWhat does an Intercultural Facilitator do?Best ever explanation of Nemawashi & Genten ShugiThe subtle art of not having to tell everythingExpertise in Japan is 10ft. wide and 1inch deep while in the US its 1inch wide and 10ft. deepStrategies for getting a positive outcome from Japanese meetingsThe reason Japanese prefer the process vs the outcomeMasafumi Otsuka: https://www.linkedin.com/in/masafumiotsuka/More Now and Zen Japan episodes: http://nowandzen.jpGrow website traffic = Zo Digital: https://www.zodigital.jp/Japan Adventures via Camper Van = Dream Drive: https://www.dreamdrive.lifeUse the code word "ZEN" to receive discounts

In this CME episode, Dr. Andy Cutler interviews Dr. Leslie Citrome about the impact of tardive dyskinesia on patient-reported outcomes and quality of life. They discuss how to correctly assess and diagnose tardive dyskinesia, as well as effective management strategies that incorporate the individual needs of patients.  Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objectives: After completing this educational activity, you should be better able to: Understand the physical, psychological, social, and occupational impacts of tardive dyskinesia (TD) on patients Identify clinical tools and patient-reported outcome measures to assess the severity and impact of TD Formulate evidence-based treatment strategies for TD that enhance patient outcomes and quality of life Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.   Activity Overview: This activity is available with audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit.   Estimated Time to Complete: 1 hour Released: October 23, 2024*   Expiration: October 22, 2027 *NEI maintains a record of participation for six (6) years.   CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD24-TD   Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ NEI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity Nurse: ANCC contact hours NEI designates this Enduring Material for a maximum of 1.0 ANCC contact hour Nurse Practitioner: ACCME AMA PRA Category 1 Credit™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 1.0 continuing education hour of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 1.0 contact hour (.10 CEU). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and is unable to report your claimed credit after this 60-day period. Physician Associate/Assistant: AAPA Category 1 CME credits NEI has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.0 AAPA Category 1 credit. Approval is valid until OCtober 22, 2027. PAs should only claim credit commensurate with the extent of their participation. Psychology: APA CE credits Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. Social Work: ASWB-ACE CE credits As a Jointly Accredited Organization, NEI is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this internet enduring course receive 1 general continuing education credits. Non-Physician Member of the Healthcare Team: Certificate of Participation NEI awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)™) to a participant who successfully completes this educational activity. Interprofessional Continuing Education: IPCE credit for learning and change This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change. Peer Review: The content was peer-reviewed by an MD, MPH specializing in forensics, psychosis, schizophrenia, mood disorders, anxiety, cognitive disorders — to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, NY Chief Medical Officer, Neuroscience Education Institute, Malvern, PA Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Leslie Citrome, MD, MPH Clinical Professor, Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY Consultant/Advisor: AbbVie/Allergan, Acadia, Adamas, Alkermes, Angelini, Astellas, Avanir, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Cerevel, Clinilabs, COMPASS, Delpor, Eisai, Enteris BioPharma, HLS Therapeutics, Idorsia, INmune Bio, Impel, Intra-Cellular Therapies, Janssen, Karuna, Lundbeck, Luye, Lyndra, MapLight, Marvin, Medavante-ProPhase, Merck, Mitsubishi-Tanabe Pharma, Neumora, Neurocrine, Neurelis, Noema, Novartis, Noven, Otsuka, Ovid, Praxis, Recordati, Relmada, Reviva, Sage, Sumitomo/Sunovion, Supernus, Teva, University of Arizona, Vanda Speakers Bureau: AbbVie/Allergan, Acadia, Alkermes, Angelini, Axsome, BioXcel, Eisai, Idorsia, Intra-Cellular Therapies, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Recordati, Sage, Sunovion, Takeda, Teva Stockholder: Bristol-Myers Squibb, Eli Lilly, J & J, Merck, Pfizer, Reviva (options) The remaining Planning Committee members, Content Editors, Peer Reviewer, and NEI planners/staff have no financial relationships to disclose. NEI planners and staff include Caroline O'Brien, Gabriela Alarcón, PhD, Andrea Zimmerman, EdD, CHCP, and Brielle Calleo. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement Contact Us: For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported by an unrestricted educational grant from Teva Pharmaceuticals.

On this episode, I'm joined by Gavin, vocalist for the band Ikaika, to chat about Lahaina one year after the fires, his taste in coffee, Hammer and Nail Fest, and Demonstration of Pacific Fury. During the episode, I was drinking Candy Cloud from Pirates of Coffee.  Episode Links: https://piratesofcoffee.com/ https://ikaikahc.bandcamp.com/album/a-demonstration-of-pacific-fury-demo https://www.etix.com/ticket/p/50872409/hammer-and-nail-fest-weekend-pass-tampa-crowbarflorida-mind https://www.beansandbreakdowns.com/

In this CME episode, Dr. Andrew Cutler interviews Dr. Charles Vega about the challenges of identifying bipolar disorder in primary care and how to over come them. They also discuss strategies for initiating and managing pharmacological treatment long term in collaboration with patients and psychiatric specialists. Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objective: After completing this educational activity, you should be better able to: Identify the key symptoms and diagnostic criteria for bipolar disorder to accurately screen and diagnose patients presenting in primary care settings Describe strategies for initiating and managing pharmacological treatment of bipolar disorder, including appropriate use of mood stabilizers, antipsychotics, and monitoring for side effects and adherence Explain the role of the primary care provider in coordinating care for bipolar disorder patients, including providing psychoeducation, determining appropriate level of care, and collaborating with mental health specialists when needed Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Activity Overview: This activity is available with audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit.   Estimated Time to Complete: 45 minutes Released: September 04, 2024*   Expiration: September 03, 2027 *NEI maintains a record of participation for six (6) years. CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD24-PrimCare Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ NEI designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity Nurse: ANCC contact hours NEI designates this Enduring Material for a maximum of 0.75 ANCC contact hour Nurse Practitioner: ACCME AMA PRA Category 1 Credits™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 0.75 continuing education hour of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 0.75 contact hour (.075 CEU). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and is unable to report your claimed credit after this 60-day period. Physician Associate/Assistant: AAPA Category 1 CME credits NEI has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 0.75 AAPA Category 1 credit. Approval is valid until September 03, 2027. PAs should only claim credit commensurate with the extent of their participation. Non-Physician Member of the Healthcare Team: Certificate of Participation NEI awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit™) to a participant who successfully completes this educational activity. Interprofessional Continuing Education: IPCE credit for learning and change This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credit for learning and change. Peer Review: The content was peer-reviewed by an MD, MPH specializing in forensics, psychosis, schizophrenia, mood disorders, anxiety, cognitive disorders — to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Any relevant financial relationships were mitigated prior to the activity being planned, developed, or presented. Disclosures are from the original live presentation, unless otherwise noted. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, NYChief Medical Officer, Neuroscience Education Institute, Malvern, PA Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Charles P. Vega, MD Clinical Professor, School of Medicine, University of California - Irvine, Orange, CA Consultant/Advisor: Boehringer Ingelheim, Exact Sciences The remaining Planning Committee member(s), Content Editor(s), Peer Reviewer(s), and NEI planners/staff have no financial relationships to disclose. NEI planners and staff include Gabriela Alarcón, PhD, Andrea Zimmerman, EdD, Samantha Joy, and Brielle Calleo. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement Contact Us: For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported solely by the provider, NEI.

Tracy Otsuka, host of the ADHD for Smart Ass Women Podcast, joins me for a conversation about how ADHD uniquely shows up in women. We dig into why it's often overlooked or misunderstood because the symptoms don't always match up with what you see in men. We break down the top three signs of ADHD, how hormonal changes play a role, and why embracing your strengths is way more effective than trying to "fix" your weaknesses. Tracy also opens up about the emotional toll ADHD can take and offers practical advice for supporting kids with ADHD. Tune in to learn how ADHD impacts women navigating divorce and get tips for handling it all with confidence and self-compassion. Featured topics: How to recognize ADHD symptoms and how to advocate for care and the right diagnosis (3:28) Understanding ADHD in women, including how it shows up and how hormonal shifts shape your experience (7:14) Supporting kids with ADHD and tackling co-parenting challenges with confidence (21:55) Managing ADHD through divorce from diagnosis to treatment (32:25) Learn more about Tracy Otsuka: Tracy Otsuka, JD, is a certified ADHD coach and the host of the ADHD for Smart Ass Women podcast. Over the past decade, she has empowered thousands of clients (from doctors and therapists to C-suite executives and entrepreneurs) to see their neurodivergence as a strength–not a weakness. Tracy leverages her analytical skills from being a lead counsel at the U.S. Securities and Exchange Commission to identify the right questions to ask her clients so they can boost their productivity, improve their finances, save failing relationships and live happier lives. Tracy's expertise and experience as an adult living with ADHD are regularly sought out by top tier media including Inc, Forbes, ADDitude magazine, and The Goal Digger Podcast. When she's not sharing her thought leadership around ADHD on other platforms, she hosts her own podcast which ranks #1 in its category and has over 5 million downloads across 160 countries. She also moderates a Facebook group with nearly 100,000 members. A married mother of two, Tracy lives in Sonoma County outside of San Francisco. Her new book, ADHD for Smart Ass Women is due out in December 2023. Resources & Links: Private Coaching with Kate Phoenix Rising: A Divorce Empowerment Collective ADHD Smarts for Women Via Character Strengths Survey Episode Link: https://kateanthony.com/podcast/episode-287-adhd-for-smart-ass-women-with-tracy-otsuka/ =================== DISCLAIMER: THE COMMENTARY AND OPINIONS AVAILABLE ON THIS PODCAST ARE FOR INFORMATIONAL AND ENTERTAINMENT PURPOSES ONLY AND NOT FOR THE PURPOSE OF PROVIDING LEGAL OR PSYCHOLOGICAL ADVICE. YOU SHOULD CONTACT AN ATTORNEY, COACH, OR THERAPIST IN YOUR STATE TO OBTAIN ADVICE WITH RESPECT TO ANY PARTICULAR ISSUE OR PROBLEM.

Tracy Otsuka, host of the ADHD for Smart Ass Women Podcast, joins me for a conversation about how ADHD uniquely shows up in women. We dig into why it's often overlooked or misunderstood because the symptoms don't always match up with what you see in men. We break down the top three signs of ADHD, how hormonal changes play a role, and why embracing your strengths is way more effective than trying to "fix" your weaknesses. Tracy also opens up about the emotional toll ADHD can take and offers practical advice for supporting kids with ADHD. Tune in to learn how ADHD impacts women navigating divorce and get tips for handling it all with confidence and self-compassion. Featured topics: How to recognize ADHD symptoms and how to advocate for care and the right diagnosis (3:28) Understanding ADHD in women, including how it shows up and how hormonal shifts shape your experience (7:14) Supporting kids with ADHD and tackling co-parenting challenges with confidence (21:55) Managing ADHD through divorce from diagnosis to treatment (32:25) Learn more about Tracy Otsuka: Tracy Otsuka, JD, is a certified ADHD coach and the host of the ADHD for Smart Ass Women podcast. Over the past decade, she has empowered thousands of clients (from doctors and therapists to C-suite executives and entrepreneurs) to see their neurodivergence as a strength–not a weakness. Tracy leverages her analytical skills from being a lead counsel at the U.S. Securities and Exchange Commission to identify the right questions to ask her clients so they can boost their productivity, improve their finances, save failing relationships and live happier lives. Tracy's expertise and experience as an adult living with ADHD are regularly sought out by top tier media including Inc, Forbes, ADDitude magazine, and The Goal Digger Podcast. When she's not sharing her thought leadership around ADHD on other platforms, she hosts her own podcast which ranks #1 in its category and has over 5 million downloads across 160 countries. She also moderates a Facebook group with nearly 100,000 members. A married mother of two, Tracy lives in Sonoma County outside of San Francisco. Her new book, ADHD for Smart Ass Women is due out in December 2023. Resources & Links: Private Coaching with Kate Phoenix Rising: A Divorce Empowerment Collective ADHD Smarts for Women Via Character Strengths Survey Episode Link: https://kateanthony.com/podcast/episode-287-adhd-for-smart-ass-women-with-tracy-otsuka/ =================== DISCLAIMER: THE COMMENTARY AND OPINIONS AVAILABLE ON THIS PODCAST ARE FOR INFORMATIONAL AND ENTERTAINMENT PURPOSES ONLY AND NOT FOR THE PURPOSE OF PROVIDING LEGAL OR PSYCHOLOGICAL ADVICE. YOU SHOULD CONTACT AN ATTORNEY, COACH, OR THERAPIST IN YOUR STATE TO OBTAIN ADVICE WITH RESPECT TO ANY PARTICULAR ISSUE OR PROBLEM. Learn more about your ad choices. Visit megaphone.fm/adchoices

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Small biopharma and contract research organizations are increasingly adopting eClinical technology to keep up with regulatory and market demands for research innovation. They are paying attention to how these tools can help throughout the study lifecycle. The survey report explores 11 types of clinical trial technology and when they are used, as well as the challenges to tech adoption and how vendors can assist. The report also discusses optimism for the future and emphasizes the importance of data reliability.The Southern Blood Center is recovering from a ransomware attack, causing them to implement manual processing methods for blood. The 5th Circuit Court handed providers a legal victory in the no surprises litigation, vacating instructions that advantaged insurers. Tenet is selling a majority stake in five Alabama hospitals for $910 million to pay down debt and focus on ambulatory surgery centers. Healthcare industry trends include the use of virtual reality, robotics, and AI to improve patient engagement and clinical decision-making. Healthcare data breaches are on the rise, with an Arkansas-based provider exposing the information of over 375,000 people.Biotech entrepreneur Arie Belldegrun has launched a new 'science-first' credit firm called Symbiotic Capital with $600 million in committed capital. Roche has licensed Sangamo's technology for another shot at developing an Alzheimer's drug by repressing the gene that produces the protein tau. Biomarin is reducing spending on its hemophilia gene therapy, Roctavian, and focusing sales in the U.S., Italy, and Germany. Biotech startup Red Queen has received $55 million in funding to develop versatile antivirals, including a COVID treatment.Sangamo Therapeutics has secured an exclusive licensing agreement with Genentech, a subsidiary of Roche, to develop novel genomic medicines for neurodegenerative diseases. Genentech will pay Sangamo $50 million in upfront fees and milestone payments as part of the potential $1.9 billion deal. In other news, Biomarin Pharmaceuticals is narrowing the focus of its hemophilia A gene therapy, Roctavian, to the U.S., Germany, and Italy in an effort to reduce costs and increase profitability by 2025.Pharma giants Pfizer, GSK, and Moderna are gearing up for the respiratory syncytial virus (RSV) season, which typically starts in the fall and peaks in the winter. RSV can be dangerous for infants and older individuals, leading to hospitalization and death. The FDA has approved three vaccines for RSV, but vaccination rates among adults over 60 are low.This week in biotech news, Jim Wilson, a prominent gene therapy researcher, is leaving UPenn to start two new spinouts. Otsuka has acquired startup Jnana in an $800 million deal, adding to the recent uptick in private biotech M&A. Biotech startup Airna has raised $60 million for RNA editing medicines, while 23andMe's board has rejected CEO Wojcicki's take-private proposal. Additionally, Biotech Red Queen has launched with $55 million to develop versatile antivirals.Stay informed with Biopharma Dive for all your biotech and pharma news needs!Support the Show.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The CEO of 23andme, Anne Wojcicki, has proposed to take the company private by buying shares at 40 cents each. GE Healthcare is facing pressure in China as hospitals delay orders, impacting revenue growth for Johnson & Johnson and Philips as well. The FDA and Health Canada are working together to raise awareness of a recall for J&J's Megadyne electrode pads. Stryker plans to be very active in mergers and acquisitions and is launching an orthopedic robot in the second half of the year. Labcorp is expanding its partnership with Ultima Genomics to boost genomic diagnostics by using a machine designed to sequence the genome for $100.Transitioning to the next segment, Moderna's shares fell due to a lower sales outlook for their RSV and COVID shots, while Otsuka acquired startup Jnana in a deal worth $800 million. Biogen is optimistic about the future of their Alzheimer's drug, Leqembi, and Cigna's CEO promises a strong defense of pharmacy benefit managers. The biotech M&A market is on the rise, with Otsuka's acquisition of Jnana being the 16th deal for a private startup with at least $50 million upfront. The industry is also exploring the use of eClinical technologies in research to improve efficiency. Overall, the biopharma sector is experiencing significant developments and changes that are shaping the industry landscape.Moving on to the following update, Moderna's stock price plummeted over 20% after the company reduced its revenue guidance for 2024 due to decreased demand for its COVID-19 vaccine in the second quarter. Meanwhile, Lilly's tirzepatide successfully cleared a Phase III cardiovascular study, showing a 38% reduction in heart failure risk. Otsuka Pharmaceutical is acquiring Jnana Therapeutics for up to $1.1 billion, adding to its drug discovery capabilities. The FDA is questioning the evidence supporting Zevra's rare disease therapy ahead of an advisory committee meeting. Novo Nordisk lost a legal case regarding price negotiations, while Sanofi sued Sarepta over alleged patent infringement.Shifting gears to marketing news, Carter's is targeting Gen Z parents by focusing on more than just cute clothing, with insights and strategy from CMO Jeff Jenkins. Meta is utilizing AI to automate creative and personalize ads in real time, leading to a 22% increase in revenue. Hyundai has split the CMO role into creative and performance positions, with Angela Zepeda becoming Chief Creative Officer. Shapermint's proprietary AI ad tool, Altair, has helped streamline content production and attract new customers. Additionally, the role of print in marketing strategies is explored in a webinar, and tips for creating successful loyalty programs are shared.Finally, pharma executives are turning their attention to health equity and increasing diversity in clinical trials. A trendline explores strategies to boost diversity in trials. While business literature like "The First 90 Days" by Michael Watkins helps with career moves, real-life medical thrillers like "Last Night in the OR" and "Empire of Pain" offer insights into healthcare and pharma. Six books that pharma execs swear by are also highlighted. Pfizer's CEO remains confident in the company's position in the obesity drug market, despite delays. The newsletter also covers inflation penalties for big pharma companies, the potential impact of a combo COVID/flu shot on vaccinations, and best practices for new drug applications and biologics license applications.That's all for today on Pharma and Biotech daily - bringing you the latest updates and insights from the world of pharmaceuticals and biotechnology.Support the Show.

Attention Deficit Hyperactivity Disorder (ADHD) isn't just a childhood condition. Diagnoses for adult women are surging, yet many struggle for years undiagnosed. Today, we're diving deep into ADHD with Tracy Otsuka, a certified ADHD coach and author of “ADHD for Smart Ass Women: How to Fall in Love with Your Neurodivergent Brain,” whose wildly popular podcast reaches millions. Tracy joins us to unpack the female experience of ADHD, from diagnosis to how symptoms in women differ from men and explores how menopause impacts an ADHD brain. We also dive into how to support friends navigating an adult diagnosis. Join us for a conversation that flips the script on ADHD—time to see your ADHD as not just “A-OK” but as brilliant! SHOW NOTES + TRANSCRIPT acertainagepod.com FOLLOW A CERTAIN AGE: Instagram Facebook LinkedIn GET INBOX INSPO: Sign up for our newsletter AGE BOLDLY We share new episodes, giveaways, links we love, and midlife resources Learn more about your ad choices. Visit megaphone.fm/adchoices

It's new watch day! Vu finally was able to purchase an Otsuka Lotec No. 6. This has been years in the making, and so far it seems that it was worth the wait. We talk all about this amazing watch and its maker, Jiro Katayama who created Otsuka Lotec. You can see photos of the watch at @thiswatchlifepodcast.

Special guest Marshall E. Cates, PharmD, BCPP, FASHP, FCCP, FALSHP, Professor of Pharmacy Practice from the McWhorter School of Pharmacy at Samford University joins us to talk about pharmacotherapy for anxiety and depression.Listen in as we discuss pharmacotherapy for managing generalized anxiety disorder and major depression, with a focus on tailoring first- or second-line options to individual patient needs.You'll also hear practical advice from Craig D. Williams, PharmD, FNLA, BCPS, a member of TRC's Editorial Advisory Board and Clinical Professor of Pharmacy Practice at the Oregon Health and Science University.For the purposes of disclosure, Dr. Cates reports relevant financial relationships [psychiatry] with Biogen, Sage Therapeutics (honorarium); Otsuka (speakers bureau).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.The clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Pharmacotherapy of Anxiety Disorders in AdultsChart: Choosing and Switching AntidepressantsChart: Combining and Augmenting AntidepressantsIf you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this CME episode, Dr. Andrew Cutler interviews Dr. Laxman Bahroo about the current landscape of tardive dyskinesia, including screening, diagnosis, and treatment. Practical strategies based on the latest data are reviewed at length, particularly for long-term management of tardive dyskinesia.  Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objectives: After completing this educational activity, you should be better able to: Consider the individual patient profile and symptoms when determining a treatment plan for patients with tardive dyskinesia Integrate latest safety, efficacy, and tolerability data of VMAT2 inhibitors into decision-making processes when considering treatment options for tardive dyskinesia Evaluate practical strategies for patient follow-up and long-term VMAT2 inhibitor treatment Evaluate and integrate recent updates and advancements regarding evidence-based treatment strategies for tardive dyskinesia Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Activity Overview: This activity is available with audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit. Estimated Time to Complete: 1 hour Released: June 26, 2024*   Expiration: June 25, 2027 *NEI maintains a record of participation for six (6) years. CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD24-02-TD Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ NEI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity Nurse: ANCC contact hours NEI designates this Enduring Material for a maximum of 1.0 ANCC contact hours Nurse Practitioner: ACCME AMA PRA Category 1 Credit™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 1.0 continuing education hour of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 1.0 contact hour (.10 CEUs). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and is unable to report your claimed credit after this 60-day period. Physician Associate/Assistant: AAPA Category 1 CME credits NEI has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.0 AAPA Category 1 credit. Approval is valid until June 25, 2027. PAs should only claim credit commensurate with the extent of their participation. Psychology: APA CE credits Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. Social Work: ASWB-ACE CE credits As a Jointly Accredited Organization, NEI is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this internet enduring course receive 1.0 general continuing education credits. Non-Physician Member of the Healthcare Team: Certificate of Participation NEI awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)™) to a participant who successfully completes this educational activity. Interprofessional Continuing Education: IPCE credit for learning and change This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change. Peer Review: The content was peer-reviewed by an MD, MPH specializing in forensics, psychosis, schizophrenia, mood disorders, anxiety, cognitive disorders — to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, NY Chief Medical Officer, Neuroscience Education Institute, Malvern, PA Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Laxman B. Bahroo, DO, MS, FAAN Professor and Residency Program Director, Department of Neurology, MedStar Georgetown University Hospital, Washington, DC Consultant/Advisor: AbbVie, Amneal, Ipsen, Kyowa Kirin, Merz, Neurocrine, Revance, Supernus Speakers Bureau: AbbVie, Acadia, Acorda, Amneal, Ipsen, Kyowa Kirin, Merz, Neurocrine, Supernus, Teva The remaining Planning Committee members, Content Editors, Peer Reviewer, and NEI planners/staff have no financial relationships to disclose. NEI planners and staff include Caroline O'Brien, Meghan Grady, Brielle Calleo, and Andrea Zimmerman, EdD. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement Contact Us: For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported by an unrestricted educational grant from Neurocrine Biosciences.

As women, it can feel like we have to do it all, yet not be “too much.” Add ADHD stigma and shame on top, and it can feel impossible. Good thing we have Tracy Otsuka to remind us that no one has ever made a difference by being “too little.” Tracy is an ADHD coach, the host of the ADHD for Smart Ass Women podcast, and author of the book with the same name! In this episode, host Laura Key and Tracy talk about how her son's diagnosis led to her own, the need for an ADHD cookbook, and challenging the status quo. Related resourcesTracy's podcast, ADHD for Smart Ass WomenTracy's book, ADHD for Smart Ass WomenADHD and women: The essentialsTo get a transcript of this show and check out more episodes, visit the ADHD Aha! podcast page at Understood.We love hearing from our listeners. Email us at ADHDAha@understood.org. Understood is a nonprofit organization dedicated to empowering people with learning and thinking differences, like ADHD and dyslexia. If you want to help us continue this work, donate at understood.org/give

In this CME episode, Dr. Andrew Cutler interviews Desiree Matthews, PMHNP-BC on the importance of engaging patients across all facets of tardive dyskinesia management beginning with screening to symptoms monitoring to treatment. The role of patient experience and preferences in shared decision-making regarding treatment for tardive dyskinesia is discussed at length.  Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objectives: After completing this educational activity, you should be better able to: Recognize the significance of comprehensive measures that assess both healthcare practitioner-perceived severity of tardive dyskinesia symptoms and the patient-reported impact of tardive dyskinesia on daily life Engage in informed discussions with patients about the rationale behind incorporating additional medications to manage side effects arising from primary antipsychotic medication Consider all facets of patient health, including physical, mental, and social well-being, when formulating strategies for managing tardive dyskinesia symptoms Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Activity Overview: This activity is available with audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit. Estimated Time to Complete: 1 hour. Released: June 05, 2024*   Expiration: June 04, 2027 *NEI maintains a record of participation for six (6) years. CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD24-01-TD Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ NEI designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity Nurse: ANCC contact hours NEI designates this Enduring Material for a maximum of 1.00 ANCC contact hours Nurse Practitioner: ACCME AMA PRA Category 1 Credit™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 0.5 continuing education hour(s) of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 1.00 contact hour(s) (.10 CEUs). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and is unable to report your claimed credit after this 60-day period. Physician Associate/Assistant: AAPA Category 1 CME credits NEI has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit(s) for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.00 AAPA Category 1 credit(s). Approval is valid until June 04, 2027. PAs should only claim credit commensurate with the extent of their participation. Psychology: APA CE credits Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. Social Work: ASWB-ACE CE credits As a Jointly Accredited Organization, NEI is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this internet enduring course receive 1 general continuing education credits. Non-Physician Member of the Healthcare Team: Certificate of Participation NEI awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)™) to a participant who successfully completes this educational activity. Peer Review: The content was peer-reviewed by an MD specializing in psychiatry — to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Any relevant financial relationships were mitigated prior to the activity being planned, developed, or presented. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, NY Chief Medical Officer, Neuroscience Education Institute, Malvern, PA Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Desiree M. Matthews, MSN, PMHNP-BC Founder and Clinical Director, Different MHP, PC, Charlotte, NC Consultant/Advisor: Alkermes, Biogen, Boehringer Ingelheim, Karuna, Indivior, Janssen Pharmaceuticals, Neurocrine Biosciences, Sage Therapeutics, Takeda, Teva Speakers Bureau: AbbVie, Axsome, Neurocrine Biosciences, Teva The remaining Planning Committee members, Content Editors, Peer Reviewer, and NEI planners/staff have no financial relationships to disclose. NEI planners and staff include Caroline O'Brien, Meghan Grady, and Andrea Zimmerman. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement Contact Us: For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported by an unrestricted educational grant from Neurocrine Biosciences.

Today I am joined with the delightful and insightful Tracy Otsuka! Tracy shares her personal journey of discovering her own ADHD after her son's diagnosis and how it led her to become a passionate advocate for women with ADHD. With her unique blend of humor, vulnerability, and wisdom, Tracy challenges the traditional narrative surrounding ADHD and sheds light on the remarkable strengths and brilliance of women with this neurodivergent superpower.As the host of the top-ranking podcast "ADHD for Smart Ass Women," Tracy has empowered thousands of women to embrace their unique brain wiring and uncover their hidden potential. Join me as we explore Tracy's inspiring story, from her early struggles with masking and self-doubt to her triumphant journey of self-discovery and advocacy. Tracy has never encountered a woman with ADHD who wasn't truly brilliant in some aspect. Tracy brings a wealth of personal and professional experience to the table. A lawyer by training, a lifelong learner, and a certified ADHD coach, Otsuka is dedicated to shifting the narrative surrounding ADHD. Her own diagnosis, which came eight months after her son's, clarified her life's many puzzles. However, she quickly realized the discourse around ADHD often focuses on the struggles, overshadowing the strengths. Otsuka discovered that her ADHD was the source of some of her most remarkable abilities. Notably, while there's frequent discussion of successful men with ADHD, women with the condition tend to be overlooked. Otsuka aims to change that, providing a space to recognize, support, and celebrate women with ADHD. These women are her tribe, and she stands as a fervent supporter and advocate for their recognition and success. Episode Highlights:[3:54] - Tracy shares how her son's struggles in school led to his ADHD diagnosis at age 12.[8:06] - The surprising realization that Tracy herself had ADHD, after her son's diagnosis.[13:27] - Navigating law school with undiagnosed ADHD and the constant feeling of not being "smart enough."[15:26] - The challenges of writing a book with ADHD and the fear of forgetting its contents.[19:05] - Brooke and Tracy bond over their shared experiences with working memory struggles.[21:20] - Tracy opens up about the devastating loss of her mother.[34:33] - The story behind the bold and unapologetic name "ADHD for Smart Ass Women."[39:18] - Tracy's nuanced perspective on whether ADHD is a superpower or a deficit.[41:18] - Strategies for staying in the task-positive network (TPN) and avoiding burnout. Connect with Tracy Otsuka:Podcast & Book: “ADHD for Smart Ass Women”: https://adhdforsmartwomen.com/  Thank you for tuning into "SuccessFULL with ADHD." If this episode has impacted you, remember to rate, follow, share, and review our podcast. Your support helps us reach and help more individuals navigating their journeys with ADHD. If you want weekly ADHD tips straight to your inbox subscribe to our newsletter at coachingwithbrooke.com/newsletter

Calling all ADHD podcasters! You're about to learn how your ADHD brain can become your greatest superpower in podcasting.    Tracy Otsuka, host of the top 0.1% ranked podcast ADHD for Smart Ass Women, joins us to share how she's tapped into her ADHD brain and harnessed it to build a budding audience of 200,000 monthly listeners.    In this episode, you'll find out: -How downsizing her team led to greater productivity -Her story of overcoming her fear of podcast guesting -Why podcast guesting is essential for anyone looking to reach new audiences   Got a minute? We'd love a review! ⭐⭐⭐⭐⭐ Visit Apple Podcasts and Spotify to leave us a review and make our day

Are you an entrepreneur with an ADHD diagnosis? Have you flipped the narrative to see your neurodivergence as a superpower? If you are intrigued by either of those questions, you don't want to miss this exciting interview with ADHD coach, Tracy Otsuka. Learn more with us in today's episode!Tracy Otsuka is a Certified ADHD Coach and the author of ADHD for Smart Ass Women: How to Fall in Love with Your Neurodivergent Brain. Tracy hosts the ADHD for Smart Ass Women podcast, where she interviews women who are thriving with ADHD; her podcast has over six million downloads! Over the past decade, Tracy has empowered thousands of clients, from doctors and therapists to C-suite executives and entrepreneurs to see their neurodivergence as a strength and not a weakness. In this interview, we dive deep into what it looks like to have ADHD, why women are less frequently diagnosed, and how it looks different for them. Tracy explains how ADHD can be a superpower, what you can do to manage its symptoms, why many entrepreneurs have it, and more.Show Highlights:Tracy's work, podcast, and book are driven by the overriding belief that ADHD is a “brain difference” and a different operating system for a “brain of interest.”Why ADHD is largely undiagnosed in women (about 75% of women with ADHD are still undiagnosed!) and how it shows upTypes of ADHD: hyperactivity, inattention, and a combo of bothADHD is often the underlying cause of anxiety and depression in women!The connection between estrogen, dopamine, and ADHD in womenMost entrepreneurs are probably somewhere on the ADHD spectrum!The “mommy factor” and Tracy's story of her son's diagnosisInside the brain of a person with ADHD . . .The seriousness of getting women with ADHD diagnosed because of higher suicide rates, trauma, etc.ADHD characteristics and symptoms (and tips and tricks for coping) will vary widely from person to personADHD can show up as a superpower because of ideas, creativity, and curiosity. Tracy's advice to someone who thinks they might have ADHDWhat Tracy's birth chart says about action, innovation, organization, and moreA glimpse into Tracy's book-writing processHear Tracy's answers to rapid-fire questions about helpful advice, morning routine, and books she's reading/recommending.Resources:Connect with Tracy Otsuka: Website, ADHD for Smart Ass Women book, ADHD for Smart Ass Women podcastAlso mentioned by Tracy: Brain Energy by Christopher M. Palmer, MDConnect with PaulaI'm doing something new and exciting in a few weeks! I'm preparing an “Ask Me Anything” episode, so please send me your questions about astrology, business strategy, marketing, our farm, or anything else you'd like to ask me. Email your questions to paula@weaveyourbliss.com with the subject line “AMA.” Are you receiving...

Spoke to the fairy godmother of ADHD herself, Tracy Otsuka. Tracy an ADHD coach and creator of a the facebook community ADHD for Smart Ass Women with almost 100,000 members. She hosts the popular podcast ADHD for Smart Ass Women, and just released the incredible resource book ADHD for Smart Ass Women which is both entertaining and an incredible educational resource. In this episode we swap hilarious stories and exchange helpful ADHD tips.Tracy's Links: ADHD for Smart Ass Women WebsiteADHD for Smart Ass Women BookSoul Slumber Party  Soul Slumber Party InstagramSoul Slumber Party TikTok Soul Slumber Party FacebookKaren Disapproves Karen Disapproves InstagramKaren Disapproves TikTok Show Inquiries soulslumberpartypod@gmail.com

Content Warning - brief mention of suicide. Today, I'm joined by Tracey Otsuka author of ADHD for Smart Ass Women. In this episode Tracy talks to us about ADHD and women.  We discuss: Gender norms and ADHD The lack of formal research on women with ADHD The connection between estrogen and dopamine Women and trauma Imposter Syndrome Procastivity ADHD & Perimenopause    Register for the ADHD Essentials Parenting Groups Here     Learn more about Tracy and her work here:  https://www.tracyotsuka.com/   Learn More about Brendan and his work at:   Learn about & Register for the The ADHD Essentials Online Parent Coaching Groups  Join The ADHD Essentials Facebook Community Check out the ADHD Essentials Website Contact Brendan at brendan@ADHDessentials.com   Men's ADHD Support Group Links: Learn more about the Men's ADHD Support Group Join the Men's ADHD Support Group's Facebook Community   

Can ADHD actually be a secret weapon for women? In this episode, discover how ADHD is a super power and how to embrace your neurodiverse ways in today's episode with special guest, Tracy Otsuka. Tracy Otsuka is a certified ADHD coach and the host of the ADHD for Smart Ass Women podcast and for over a decade, she has empowered thousands of women  to see their neurodivergence as a strength–not a weakness. Listen as we talk about: Understanding ADHD as a difference, not a disorder.Exploring the unique manifestations of ADHD in women at different stages of life.Celebrating our differences and embracing neurodiversity to unlock personal growth and success in our lives.Tips to thrive while speaking on stages with ADHD.Learn more from Tracy Otsuka:adhdforsmartwomen.com/bookhttps://www.instagram.com/tracyotsukahttps://www.instagram.com/tracyotsukaReady to thrive on stages too? The doors are now open to Command The Stage VIP. Get 1:1 mentorship on your next speaking event or developing a new talk. DM VIP on instagram @katherine_beck_ to get all the details on working together.Ready to speak on more stages and leverage your voice to grow your business?Join me for a FREE masterclass on how to Speak On More Stages & become known as a sought-after thought leader in your niche. Register for the Speak On More Stages Masterclass Here.If this episode inspires you then I'd love to hear from you! Take a screenshot of you listening on your device, post it to your Instagram stories, and tag me @katherine_beck_ Have you left a review? If you loved this episode show your support by leaving a rating at review right here. Thanks for supporting the show!

We begin part two with this doozy: Tracy Otsuka shares that she never struggled with motherhood. Why? Her husband served as her executive functioning, and they split tasks based on what they were both good at. Revolutionary, huh? In this episode...Tracy gives us the most beautiful reality check about what it really means to be a "good mom." It's about emotional connection, not the "administrative crap.""What happens to women with ADHD is that they feel they cannot be who they truly are." Tracy's goal is to help women be more of who they really are, not less.Main character mom goals: Tracy's parenting goal was that her kids grow up to be proud of her. She reminds us how important it is that we "show our daughters what it looks like to be ourselves.""You wouldn't call it people pleasing if you really wanted to do it." We discuss how people pleasing shows up in ADHD motherhood. Tracy talks about using positive and negative emotions a barometer to recognize when we are doing things for the right reasons.  Tracy reminds us of the power and importance of gratitude for ADHD women, especially as a tool to combat the negativity and worry when we are stuck in default mode network (DMN). ABOUT TRACY OTSUKATracy Otsuka, JD, is a certified ADHD coach and the host of the ADHD for Smart Ass Women podcast. Over the past decade, she has empowered thousands of clients (from doctors and therapists to C-suite executives and entrepreneurs) to see their neurodivergence as a strength–not a weakness. Tracy leverages her analytical skills from being a lead counsel at the U.S. Securities and Exchange Commission to identify the right questions to ask her clients so they can boost their productivity, improve their finances, save failing relationships and live happier lives.Tracy's expertise and experience as an adult living with ADHD are regularly sought out by top tier media including Inc, Forbes, ADDitude magazine, and The Goal Digger Podcast.  She hosts her own podcast which ranks #1 in its category and has over 5 million downloads across 160 countries. She also moderates a Facebook group with nearly 100,000 members. A married mother of two, Tracy lives in Sonoma County outside of San Francisco.Tracy's website: https://www.tracyotsuka.com/Tracy's podcast: https://podcasts.apple.com/gb/podcast/adhd-for-smart-ass-women-with-tracy-otsuka/id1443678424Tracy's instagram:  https://www.instagram.com/tracyotsuka/?hl=enIf you are nodding your head to everything in this episode, and you've been looking for your people and feel like you've FINALLY found them, please join us in the ADHD Mom Club. We cannot wait to see you there:https://www.motherplusser.com/ADHD-mom-club-waitlistMOTHER PLUS INSTAGRAM: https://www.instagram.com/mother_plus_podcast/MOTHER PLUS FACEBOOK: https://www.facebook.com/motherpluspodcastMOTHER PLUS PERMISSION SLIP: https://www.motherplusser.com/Permission-SlipMOTHER PLUS NEWSLETTER: https://www.motherplusser.com/signup-pageMOTHER PLUS BLOG: https://www.motherplusser.com/blog

ADHD and neurodiversity can often be our biggest superpower. I've invited best-selling author and my friend, Tracy Otsuka, to share her experience and insights on ADHD and how we can use it to our advantage. In this episode, you'll discover: Discover steps you can take to thrive in your personal and professional life Learn the importance of knowing yourself Define and understand your mind on a deeper level For full show notes, go to schulmanart.com/302  

In Part I of our conversation with the incomparable Tracy Otsuka, we share the story of how we came to find her, and introduce her podcast and incredible book to our listeners. We discuss Tracy's superpowers as a woman with ADHD, and how her story may be unlike other ADHD women because of her confidence and comfort level with being "different." The Cliff's Notes Version:Tracy shares something that sets her apart from other ADHD women—she has never cared that she is different, and has used that to her advantage. Women with undiagnosed ADHD may mask, compensate, and craft harmful narratives like, "I guess I'm not that smart" or "I have no idea what's going on." Tracy breaks down hyperactive and inattentive type ADHD and how they affect confidence and learned helplessness.We dive into why motherhood can be more difficult for women with ADHD—our daily routines feel like Groundhog's Day, the tasks required can be boring for our creative brains, and the compromised Executive Functioning skills create overwhelm. Tracy breaks down DMN (default mode network) and TPN (task positive network), and explains how the challenge toggling between them makes transitions more difficult for ADHD women. We learn some strategies to manage our DMN and TPN and how to work with our brains, taking charge and learning to switch gears. ABOUT TRACY OTSUKATracy Otsuka, JD, is a certified ADHD coach and the host of the ADHD for Smart Ass Women podcast. Over the past decade, she has empowered thousands of clients (from doctors and therapists to C-suite executives and entrepreneurs) to see their neurodivergence as a strength–not a weakness. Tracy leverages her analytical skills from being a lead counsel at the U.S. Securities and Exchange Commission to identify the right questions to ask her clients so they can boost their productivity, improve their finances, save failing relationships and live happier lives.Tracy's expertise and experience as an adult living with ADHD are regularly sought out by top tier media including Inc, Forbes, ADDitude magazine, and The Goal Digger Podcast.  She hosts her own podcast which ranks #1 in its category and has over 5 million downloads across 160 countries. She also moderates a Facebook group with nearly 100,000 members. A married mother of two, Tracy lives in Sonoma County outside of San Francisco.Tracy's website: https://www.tracyotsuka.com/Tracy's podcast: https://podcasts.apple.com/gb/podcast/adhd-for-smart-ass-women-with-tracy-otsuka/id1443678424 Tracy's instagram:  https://www.instagram.com/tracyotsuka/?hl=enIf you are nodding your head to everything in this episode, and you've been looking for your people and feel like you've FINALLY found them, please join us in the ADHD Mom Club. We cannot wait to see you there:https://www.motherplusser.com/ADHD-mom-club-waitlistMOTHER PLUS INSTAGRAM: https://www.instagram.com/mother_plus_podcast/MOTHER PLUS FACEBOOK: https://www.facebook.com/motherpluspodcastMOTHER PLUS PERMISSION SLIP: https://www.motherplusser.com/Permission-SlipMOTHER PLUS NEWSLETTER: https://www.motherplusser.com/signup-pageMOTHER PLUS BLOG: https://www.motherplusser.com/blog

Join us for part 2 of BrainStorm's interview with Dr. Brent Forester, Chairman of the Department of Psychiatry, and Director of Behavioral Health at Tufts Medical Center. Host Meryl Comer and Dr. Forester discuss the need for a change of mindset by the medical community and the public in general when it comes to dementia.Dr. Forester, author of The Complete Family Guide to Dementia, Everything You Need to Know to Help Your Parent and Yourself, explains how countless families grappling with the complexities of caring for a parent with dementia are frustrated by the scarcity of neurologists. He emphasizes the importance of focusing on what can be done for people with dementia rather than dwelling on limitations. His advice to caregivers - adopt a "caring smarter, not harder" approach. Comer and Dr. Forester delve into strategies for observing and addressing behavioral symptoms in dementia patients, as well as as new FDA approved treatment for psychosis and agitation in AD. Whether you're directly impacted by dementia or not, you'll leave this episode with valuable insights. Tune in today!This episode is sponsored by Otsuka and Lundbeck. Support the show

Laura Warrell is back to praise Julia Otsuka's "The Swimmers". We specifically talk about how difficult is to write in third person plural but we both couldn't put the book down. The Swimmers: https://www.amazon.com/Swimmers-novel-Julie-Otsuka/dp/0593466624/ref=sr_1_1?crid=HTD04TIH3JME&dib=eyJ2IjoiMSJ9.4NaEfZ2_fThQKp51HQYfO3tojtO-OKvYCsK1Cu5scz02W-g9vy9Ikgj5ZD2cawb1oSUKPy23mGNPLiw2Ppd2o2bdGNECXGyLIWIbIuBYVBnUV7tsSSMMtPavy_IzOtag.ta8FMgR9TXsaaWJw4lEar52JTZ4XxgzbKt9CHQvezlg&dib_tag=se&keywords=the+swimmers+a+novel+by+julie+otsuka&qid=1711402039&sprefix=The+swimmers++%2Caps%2C339&sr=8-1Sweet, Soft, Plenty Rhythm https://www.amazon.com/Sweet-Soft-Plenty-Rhythm-Novel/dp/0593466535/ref=sr_1_1?crid=22XGIM561EEER&dib=eyJ2IjoiMSJ9.Mm97SQJVc54eyalJbO4_4w.rgiHzIQJ5RgDBwKZZ2AOKFd5sSl1K-KXGltumO1uq8Y&dib_tag=se&keywords=laura+warell+sweet+soft+plenty+rhythm&qid=1711401623&sprefix=laura+warell+sweet+soft+plenty+rhytm%2Caps%2C175&sr=8-1

If you're facing the challenge of caring for a parent with dementia, you are not alone. In this episode of BrainStorm Brent Forester, MD, MSc, Psychiatrist in Chief, Chairman of the Department of Psychiatry, and Director of Behavioral Health at Tufts Medical Center, discussed the complexity of dementia care and the importance of a holistic approach with host Meryl Comer. Dr. Forester, author of The Complete Family Guide to Dementia, everything You Need to Know to Help Your Parent and Yourself, provided crucial insight for effective management of behaviors, and tips to facilitate communication with healthcare providers. The needs of both patients and caregivers must always be considered during the decision-making process.  You won't want to miss this episode!This episode is sponsored by Otsuka and Lundbeck.Produced by Susan Quirk and Amber RonigerSupport the show

Today we are answering the question- do you have adult onset ADHD- with Tracy Otsuka. Tracy is a certified ADHD coach and the author of “ADHD For Smart Ass Women. She believes that there is a peri-menopausal onset of ADHD caused by changing estrogen levels. Since there has not been a lot of research into what ADHD looks like in women, many women are misdiagnosed or mis-medicated. Tracy is on a mission to educate as many women as she can about the results of her research on adult onset ADHD in midlife women. She removes the stigma and misconceptions of ADHD as well as highlighting the superpowers. This episode is full of practical information and is a terrific resource for anyone who may feel that their brains are changing in midlife. There's nothing to fear only strategies to learn and steps to take toward taking action. Please grab a cuppa something wonderful and join us for this encouraging, enlightening conversation.  https://www.tracyotsuka.com/ 

In this empowering episode, we sit down with Tracy Otsuka, a renowned ADHD advocate, author, and host of the popular "ADHD for Smart Ass Women" podcast. Tracy shares her personal journey of discovery and transformation, beginning with her son's ADHD diagnosis and leading to her own later in life. She illuminates the unique challenges and strengths of living with ADHD, especially for women, who often face misdiagnosis or misunderstanding. Tracy delves into the heart of misconceptions surrounding ADHD, providing insightful commentary on how societal norms often limit those with the condition. She passionately argues against lowering expectations, showcasing instead how individuals can harness their ADHD traits as unique strengths. From hyperfocus to creativity, Tracy discusses how what is often seen as a hurdle can be transformed into a powerful advantage in both personal and professional realms. Join us as Tracy Otsuka offers practical advice for those navigating ADHD, highlights the importance of focusing on strengths over limitations, and shares success stories from her community. This episode is not just a conversation; it's a call to action for changing the way we talk about ADHD and women. Whether you have ADHD, know someone who does, or just love inspiring stories of overcoming obstacles and societal labels, this episode is for you. Get ready to be motivated, educated, and perhaps see ADHD in a whole new light. To check out Tracy's book, "ADHD for Smart Ass Women: How to Fall in Love with Your Neurodivergent Brain", head on over to Amazon (affiliate link): https://amzn.to/3SnDhhC Disclaimer: Not advice. Educational purposes only. Not an endorsement for or against. Results not vetted. Views of the guests do not represent those of the host or show. Do your due diligence. Click here to join PodMatch (the "AirBNB" of Podcasting): https://www.joinpodmatch.com/drchrisloomdphd We couldn't do it without the support of our listeners. To help support the show: CashApp- https://cash.app/$drchrisloomdphd Venmo- https://account.venmo.com/u/Chris-Loo-4 Buy Me a Coffee- https://www.buymeacoffee.com/chrisJx Thank you to our sponsor, CityVest: https://bit.ly/37AOgkp Click here to schedule a 1-on-1 private coaching call: https://www.drchrisloomdphd.com/book-online Click here to purchase my books on Amazon: https://amzn.to/2PaQn4p Follow our YouTube channel: https://www.youtube.com/chL1357 Follow us on Twitter: https://www.twitter.com/drchrisloomdphd Follow us on Instagram: https://www.instagram.com/thereal_drchrisloo Follow us on Threads: https://www.threads.net/@thereal_drchrisloo Follow us on TikTok: https://www.tiktok.com/@drchrisloomddphd Follow the podcast on Spotify: ⁠https://podcasters.spotify.com/pod/show/christopher-loo⁠ Subscribe to our Substack newsletter: https://substack.com/@drchrisloomdphd1 Subscribe to our Medium newsletter: https://medium.com/@drchrisloomdphd Subscribe to our email newsletter: ⁠https://financial-freedom-for-physicians.ck.page/b4622e816d⁠ Subscribe to our LinkedIn newsletter: https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=6992935013231071233 Join our Patreon Community: https://www.patreon.com/user?u=87512799 Join our Spotify Community: ⁠https://podcasters.spotify.com/pod/show/christopher-loo/subscribe⁠ Thank you to our advertisers on Spotify. Financial Freedom for Physicians, Copyright 2024

In this podcast episode, Dr. Christine Li was invited to interview Tracy Otsuka on Tracy's podcast called ADHD for Smart Ass Women to do a grand introduction for the release of Her book by the same name, ADHD for Smart Ass Women. Listen in as Tracy delves into key insights from her book and explores the unique perspective of women with ADHD, discussing topics such as attention, focus, creativity, and positive emotion. And stay tuned! Tracy shares some valuable insights, and provides a glimpse into the world of smart and assertive women navigating the challenges and strengths associated with ADHD. Tracy Otsuka, is the host of the podcast, ADHD for Smart Ass Women. With over a million and a half downloads, it is ranked in the top one-half percent of all podcasts in the world on any subject. Her listeners are quick-witted, high-ability and like Tracy, see their ADHD traits as more positive than negative. Tracy is also a certified ADHD coach who masterminds Your ADHD Brain is A-OK which uses her patented Coretography system to help ADHD women discover their strengths, step into their purpose and live to their potential, as well as the creator of the A-OK! EVERY DAY planning system for the ADHD brain.Timestamps:•[12:27] Tracy shares her reasoning for writing this book - to help even more women!•[18:54] “People assume that when you have ADHD, you're lazy, unmotivated, and not living to your full potential.”  •[20:43] “So instead of worrying about All the stuff that we can't do, what if we focus on what we can do and what we do well, right, with our high energy and our great creativity and our hyper focused interests…” •[26:42] Tracy discusses some of the stats of women with ADHD and how they struggle more than men do after diagnosis due to societal roles and sexism. For more information on the Make Time for Success podcast, visit: https://www.maketimeforsuccesspodcast.comGain Access to Dr. Christine Li's Free Resource Library where she offers you 12 downloadable tools and templates to help you bypass the impulse to procrastinate. CLICK HERE NOW TO CLAIM YOUR FREE RESOURCES: https://procrastinationcoach.mykajabi.com/freelibraryTo work with Dr. Li on a weekly basis in her coaching and accountability program, please register for The Success Lab here: https://www.procrastinationcoach.com/labConnect with Us!Dr. Christine LiWebsite: https://www.procrastinationcoach.comFacebook: https://www.facebook.com/groups/procrastinationcoachInstagram: https://www.instagram.com/procrastinationcoach/TikTok: https://www.tiktok.com/@procrastinationcoachThe Success Lab: https://maketimeforsuccesspodcast.com/labTracy OtsukaWebsite: https://www.tracyotsuka.com/Facebook: https://www.facebook.com/heytracyotsukaInstagram: https://www.instagram.com/tracyotsuka/LinkedIn: https://www.linkedin.com/in/tracyotsuka/Tracy's Podcast: https://adhdforsmartwomen.com/podcastLink to purchase Tracy's book: https://adhdforsmartwomen.com/book#launch-section-3

Many times ADHD in women goes undiagnosed for years. My guest today didn't know about her own ADHD until her son was diagnosed--she just always thought she had a weird brain. Today, in this Thin Thinking Episode, we are delving deep into the world of ADHD with none other than Tracy Otsuka, the brilliant mind behind the groundbreaking book, ADHD for Smart Ass Women: How to Fall in Love with Your Neurodivergent Brain. Tracy, a certified ADHD coach and the charismatic host of the wildly popular podcast, ADHD for Smart Ass Women, is set to challenge stereotypes and reshape perceptions surrounding ADHD in women. Prepare to be captivated as Tracy shares her expertise, personal stories, and the transformative message of her book. Whether you have a personal connection to ADHD or are simply curious about the intricacies of the neurodiverse brain, this episode promises to be an eye-opener. Tracy also invites us to view ADHD through a new lens, recognizing its unique place in the beautiful tapestry of human diversity. So, set aside that to-do list for a moment and join us as we embark on a journey of inspiration and challenge. Come on in.   Check out Tracy's book, ADHD For Smart Ass Women here.   In This Episode, You'll Also Learn… Who is Tracy Otsuka, what she does, and who she helps. The definition of ADHD and why women who have ADHD are often diagnosed with anxiety and depression. ADHD and weight management: its relation and how women with ADHD are more prone to eating disorders.    Links Mentioned in the Episode: Join my FREE Masterclass:  "How to Stop the "Start Over Tomorrow" Weight Struggle Cycle and Begin Releasing Weight for Good." Sign up for the FREE HYPNOSIS DOWNLOAD : Shift Out of Sugar Cravings My book, From Fat to Thin Thinking: Unlock Your Mind for Permanent Weight Loss (Includes a 30-day hypnosis process.) What would you love to hear about on the podcast? Click here and let me know Subscribe to the email list so that you never miss an episode! Get more thin thinking tools and strategies  

Have you struggled with anxiety, depression, disordered eating and drinking, and a lack of purpose-driven joy in your life?   The mistake most of us make is to assume that our inability to function like a “normal person” means that something is wrong…like dysfunctional brain chemistry, a screwed-up personality or a lack of motivation and discipline..   And so we do our best to fix, hide, cope and pretend to be normal…all the while feeling like an outsider looking in…wondering why life seems less complicated for everyone else.   My guest today is Tracy Otsuka…author of the new best-selling book, ADHD for Smart Ass Women. Tracy teaches ADHD women how to use their brilliant minds to build the life they want by embracing their too-muchness and focusing on their strengths.    By the end of our conversation, you'll learn Why ADHD is often misdiagnosed as anxiety, depression and other personality disorders in women ADHD is not a disorder you need to recover from…it's a tool you can learn to use to your advantage How to know if you have a neurotypical or neurodivergent brain…without asking your doctor.  How to cross the bridge between knowing who you really are and actually living the life of your dreams   When you're finished listening, I'd love to hear your biggest takeaway. Share the episode (or take a screenshot) and post on FB/IG. Tag me @recoverwithcolleen and I'll be sure to personally respond.   Find Tracy Otsuka and her book at https://adhdforsmartwomen.com/   Do you drink 10 or more drinks per week and have a high tolerance that undermines your willpower? Register for Thursday's Free Live Training for Moderate Drinking so you can stop obsessing about alcohol. Get the roadmap, timeline and tools for my Accelerated Recovery Process© so you focus on what really matters and just drink like a normal person.   Get on my insider's email list to receive weekly insights that will accelerate your recovery and also early-bird access to monthly workshops and events like recovery storytelling and breathwork.   

Have you ever felt like your brain works differently, especially as a woman, leading you to wonder if there's more to your challenges with focus, motivation, and achievement than meets the eye?   In this enlightening conversation, Tracy Otsuka joins her host to dive deep into the world of ADHD in women. They discuss Tracy's journey of discovering her own ADHD and how it influenced her son, creating a deeper understanding of the different manifestations of the disorder in women. Tracy sheds light on how traditional ideas of achievement, the myth of 'impostor syndrome', productivity misconceptions, importance-driven brains versus interest-driven brains, and more all tie into the experience of ADHD. She also shares insights on how ADHD can often be misdiagnosed as anxiety or depression in women due to societal expectations and gender roles. Furthermore, she explores the effects of hormones and trauma in women with ADHD. Tracy offers her perspective on dealing with the challenges of ADHD, including the positive approach she used while writing her book 'ADHD for Smart Ass Women' amidst personal challenges.   [00:00 - 14:52] Understanding ADHD on Women and Its Impact Tracy discusses her journey with ADHD, initially unrecognized by both herself and her son. Tracy delves into the process of learning about ADHD, particularly its manifestation in women, and how she began to educate herself and others. The experiences of ADHD in women are different, and many are misdiagnosed or misunderstood.   [14:52 - 33:38] ADHD and Its Connection to Addiction Tracy and Amanda delve into the role of dopamine in ADHD, particularly in the context of executive functioning and motivation. Hormonal changes during puberty, pregnancy, and menopause can exacerbate ADHD symptoms in women. Tracy talks about the societal misconceptions surrounding ADHD and creativity, debunking myths about the need for mental health struggles to fuel creativity.   [33:38 - 48:20] The Challenge of Starting and Stopping Tasks with ADHD Tracy emphasizes the importance of focusing on strengths and positive emotions for individuals with ADHD, rather than dwelling on their limitations. It is important to find one's purpose, which often involves connecting a personal passion with an element of service to others. Neurobiology, particularly related to dopamine, can lead to substance use disorders. Tracy touches upon the relationship between trauma and addiction, suggesting that while not all trauma leads to addiction, addiction often stems from some form of trauma.  Tracy and Amanda discuss the importance of providing accurate information and support to women with ADHD to help them understand and manage their condition effectively.   [48:20 - 57:16] ADHD for Smart Ass (Sober) Women Tracy reflects on how writing the book was a significant personal development journey. Discussing the book post-writing helped her process and clarify her message, which aligns with the typical processing style of people with ADHD. Tracy shares a productivity hack she used: a time management cube that helped her initiate and maintain focus on writing tasks.   Quotes:   "Outwardly, society looks at you and goes, 'Oh my gosh, she's a powerhouse, she's successful.' But inside, we feel Imposter syndrome. We're not living to our potential." - Tracy Otsuka   "Writing a book is probably after starting a podcast is, and maybe they're equal, the best self-development that you can do." - Tracy Otsuka   "We struggle to start, but guess what? We also struggle to stop. It's transitions. So if we can just start, all of a sudden it's emotion." - Tracy Otsuka   "This is more than pages in a book. This is about changing chapters in women's lives. And ultimately, I hope we do so much more than that. I hope we rewrite the ending." - Tracy Otsuka     Connect with Tracy Otsuka! Instagram: @tracyotsuka Podcast: ADHD for Smart Ass Women Book: ADHD for Smart-Ass Women     Learn more by connecting with Amanda through Instagram or visit AmandaKuda.com.    It's time to unbottle your potential! Join the Awaken without Alcohol Program, where you'll learn the combined power of elective sobriety, spirituality & manifestation.  

ADHD is one of the most common neurological disor­ders in the world, yet a staggering 75 percent of girls and women remain undiagnosed. Symptoms look different in women (it looks like anxiety, depression and issues with work­ing memory, sleep, energy, and concentration), so many ADHD women are left to navigate a society that fails to understand their struggles and gifts.   Enter certified ADHD coach and podcast host Tracy Otsuka. Armed with her experience coaching thou­sands of women, cutting-edge medical research, and personal insights from her own diagnosis, she offers hope for women with ADHD.   Learn more about Tracy and her new book ADHD for Smart Ass Women here: https://www.tracyotsuka.com/     You can find more Clutterbug content here: Website: http://www.clutterbug.me YouTube: https://www.youtube.com/@clutterbug TikTok: https://www.tiktok.com/@clutterbug_me Instagram: https://www.instagram.com/clutterbug_me/ Facebook: https://www.facebook.com/Clutterbug.Me/   #clutterbug #podcast    

This week we're having an insightful and hope-filled conversation with Tracy Otsuka who is a Certified ADHD coach! We're discussing the prevalence of ADHD among female entrepreneurs, how they're often undiagnosed, and strategies for thriving with a beautifully neurodivergent brain. **“How to Sell Your Stuff on Etsy” is not affiliated with or endorsed by Etsy.com STUFF I MENTIONED: ➡️Join the No-Negativity How to Sell Your Stuff Fam Facebook Group: https://www.facebook.com/groups/700940162133350/ ➡️ The Bear App for notetaking: https://bear.app/ ➡️ HeartMath Inner Balance tool for anxiety (get you out of fight or flight): https://store.heartmath.com/inner-balance-lightning/ ➡️ Breaking the Habit of Being Yourself – book by Joe Dispenza: https://amzn.to/41uVDBo   FIND TRACY: ADHD For Smart Ass Women by Tracy Otsuka: https://amzn.to/3Nwp4x1 Her book comes out December 26, 2023! Check out her podcast: “ADHD for Smart Ass Women” https://adhdforsmartwomen.com/podcast ADHD Courses: https://adhdforsmartwomen.com/learn Main website: https://adhdforsmartwomen.com/     WHAT'S HAPPENING NOW: ⭐ Interested in using AI to create digital Etsy products? Get immediate access to my AI Workshop replay including 20 Midjourney prompts, tutorials for Canva, Midjourney, and ChatGPT, PLUS other resources here: https://www.howtosellyourstuff.com/ai-workshop ⭐ Get my free list of 100 in Demand Micro-Niche Keywords: https://www.howtosellyourstuff.com/Micro-Niche-Demand  ⭐ Join the $4.99 monthly subscription to the In Demand Micro-Niche Keywords List: https://www.howtosellyourstuff.com/micro-niche-member  (You'll get ongoing access to the ever growing of list of hundreds--soon to be thousands-- of micro-niche opportunities on Etsy!)  ---------------------------------------------   ⭐Book a one-on-one Etsy coaching session with Lizzie: https://www.howtosellyourstuff.com/coaching ⭐Apply to be a Podcast Guest: https://bit.ly/48hFD8X Find me on Instagram and TikTok @HowtoSellYourStuff   FREE ETSY MASTERCLASS: https://www.howtosellyourstuff.com/masterclass FREE PDF DOWNLOAD: “4 Strategies I Used to Grow My Etsy Shop from $25 to $6000k/month”: https://www.howtosellyourstuff.com/site/4-strategies-opt-in   Grab my UPDATED Etsy Course for physical product sellers: “Listings that Sell 2.0” and learn how to skyrocket your Etsy business: https://www.howtosellyourstuff.com/etsy-listings-that-sell    ----- HOW TO SELL YOUR STUFF WEBSITE: https://www.howtosellyourstuff.com/ HOW TO SELL YOUR STUFF INSTAGRAM: https://www.instagram.com/howtosellyourstuff/ HOW TO SELL YOUR STUFF SHOWNOTES: https://www.howtosellyourstuff.com/blog/108 ------- THIS EPISODE IS SPONSORED BY: The Etsy SEO Workshop! Ok so you've heard me say it again and again—your SEO or search engine optimization is CRITICAL to your success on Etsy. Scootch in-- because I'm teaching you the exact SEO research strategy I used to build a multiple 6-figure Etsy shop. No matter what you're selling on Etsy—this workshop will show you how to compete in the Etsy search results and teach you research skills you can use in countless business applications. Learn more and grab your seat at https://www.howtosellyourstuff.com/SEO AND Everbee is a FREE tool that can help you find trends, products, and niches that are hot sellers on Etsy right now. I use it to learn everything about best-sellers and high performing listings. It shows me how many sales a shop makes from each listing, how much money an individual listing is earning them, how old the listing is, what their tags are and how competitive they are. It gives me an at a glance view of all the shop data and competitor listing data I need to help my students and myself find ways to penetrate the market. Here is a quick Youtube tutorial showing you how I use it: https://youtu.be/4SUdnatddMU And here is a link to get started with a FREE account: https://www.everbee.io/?via=lizzie So if you don't have it yet— jump on that today. I'm so excited for you to get this edge on the market! You're going to love it!   *Some of the links above are affiliate links which means I'll receive a commission if you purchase through my link, at no extra cost to you. You can see my affiliate disclosure here: https://www.howtosellyourstuff.com/affiliate-disclosure

This is going to be a very different episode than anything we've ever done here. I have invited my good friend, Dr. Christine Lee, to the podcast to interview me about my new book, ADHD for SMART ASS WOMEN. Christine is a procrastination coach, a seasoned clinical psychologist, and was the first ever guest on my podcast, which makes her the perfect person to help me reflect back on how far we've come and what I'm hoping for this book.   Christine and I discuss my relationship with control and how that played out during the writing process, why writing this book has been both the most challenging and one of the most rewarding experiences of my life, what we have to gain when we push ourselves past our comfort zones, and the lessons I hope ADHD women will take away from my work.   I have spent two and a half years pouring myself into this book and I'm so delighted to finally share it with you, our wonderful listeners, who reminded me why I was writing it every step of the way.   Resources: